Phantomics announced that it won the Silver Award in the Oral Presentation category of the Best Trainee Scientific Awards at the 12th International Congress on Magnetic Resonance Imaging (ICMRI 2024). The award was presented to Jae-Yoon Shim, Senior Researcher in the Product R&D Division of Phantomics, for his presentation titled “Development and Validation of Automatic LGE Analysis Methods for Cardiac MRI in Hypertrophic Cardiomyopathy.”
ICMRI, organized annually by the Korean Society of Magnetic Resonance in Medicine (KSMRM), brings together MRI researchers from around the world to discuss clinical applications and advancements in MRI imaging technology.
At the event, Senior Researcher Shim delivered an oral presentation on his team’s development and validation of an automatic LGE (Late Gadolinium Enhancement) analysis method for cardiac MRI.
According to the research team, LGE imaging is widely used to quantitatively measure cardiac tissue fibrosis or scarring. The most commonly employed techniques for quantitative LGE analysis are STRM and FWHM. However, both methods require manual identification of the reference regions, posing limitations in standardization and efficiency.
To address this, the Phantomics research team developed an image processing method that automatically identifies reference regions for each analysis technique. This method was applied to cases of hypertrophic cardiomyopathy, demonstrating the clinical utility of automatic LGE analysis.
Pan Ki Kim, Co-CEO of Phantomics, stated, “We are delighted that our outstanding research outcomes have been recognized internationally through this Silver Award at ICMRI. Moving forward, Phantomics will continue to develop automated technologies that are practical in clinical settings, contributing to the popularization of cardiac MRI and advancements in tackling cardiovascular diseases.”
Phantomics has developed Myomics, an AI-powered solution that reduces cardiac MRI analysis time from the conventional 30 minutes to under 2 minutes while achieving biopsy-level diagnostic accuracy. Myomics enables safe and precise diagnosis of suspected myocardial diseases such as heart failure, myocardial infarction, myocarditis, and amyloidosis. This allows medical professionals to diagnose patients more efficiently and promptly.
By integrating cutting-edge AI technology into cardiac MRI analysis, Phantomics continues to lead innovation in the fight against cardiovascular diseases.
Read Article
Phantomics announced that it won the Silver Award in the Oral Presentation category of the Best Trainee Scientific Awards at the 12th International Congress on Magnetic Resonance Imaging (ICMRI 2024). The award was presented to Jae-Yoon Shim, Senior Researcher in the Product R&D Division of Phantomics, for his presentation titled “Development and Validation of Automatic LGE Analysis Methods for Cardiac MRI in Hypertrophic Cardiomyopathy.”
ICMRI, organized annually by the Korean Society of Magnetic Resonance in Medicine (KSMRM), brings together MRI researchers from around the world to discuss clinical applications and advancements in MRI imaging technology.
At the event, Senior Researcher Shim delivered an oral presentation on his team’s development and validation of an automatic LGE (Late Gadolinium Enhancement) analysis method for cardiac MRI.
According to the research team, LGE imaging is widely used to quantitatively measure cardiac tissue fibrosis or scarring. The most commonly employed techniques for quantitative LGE analysis are STRM and FWHM. However, both methods require manual identification of the reference regions, posing limitations in standardization and efficiency.
To address this, the Phantomics research team developed an image processing method that automatically identifies reference regions for each analysis technique. This method was applied to cases of hypertrophic cardiomyopathy, demonstrating the clinical utility of automatic LGE analysis.
Pan Ki Kim, Co-CEO of Phantomics, stated, “We are delighted that our outstanding research outcomes have been recognized internationally through this Silver Award at ICMRI. Moving forward, Phantomics will continue to develop automated technologies that are practical in clinical settings, contributing to the popularization of cardiac MRI and advancements in tackling cardiovascular diseases.”
Phantomics has developed Myomics, an AI-powered solution that reduces cardiac MRI analysis time from the conventional 30 minutes to under 2 minutes while achieving biopsy-level diagnostic accuracy. Myomics enables safe and precise diagnosis of suspected myocardial diseases such as heart failure, myocardial infarction, myocarditis, and amyloidosis. This allows medical professionals to diagnose patients more efficiently and promptly.
By integrating cutting-edge AI technology into cardiac MRI analysis, Phantomics continues to lead innovation in the fight against cardiovascular diseases.
Read Article